ADC Therapeutics SA ADCT
$ 1.96
-4.85%
Annual report 2022
added 11-09-2024
Country |
- |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NYSE |
CEO |
Dr. Christopher J. Martin |
Employees in the company |
125 |
Shares |
- |
Market Cap[1] |
$ 105 M |
EBITDA (LTM) |
$ -239 M |
P/E (LTM) |
-0.99 |
P/S (LTM) |
12.46 |
EPS (LTM) |
-2.77 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.